[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100478358":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":12,"responsibleParty":29,"collaborators":10,"id":32,"slug":10,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":35,"acronym":10,"eligibilityCriteria":36,"healthyVolunteers":33,"sex":37,"minAge":38,"maxAge":10,"enrollmentInfo":39,"targetDuration":10,"studyType":42,"phases":10,"briefSummary":43,"conditions":44,"keywords":47,"overallStatus":15,"whyStopped":10,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},{"fullName":5,"class":6},"University Hospital of Ferrara","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Beta-thalassemia",null,"Patients with Beta-thalassemia undergoing a cardiological evaluation",[13],{"facility":14,"status":15,"city":16,"state":10,"zip":10,"country":17,"cosmosGeoPoint":18,"geoPoint":23,"contacts":24},"Matteo Bertini","RECRUITING","Ferrara","Italy",{"type":19,"coordinates":20},"Point",[21,22],11.62057,44.83804,{"lat":22,"lon":21},[25],{"name":14,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","+39 0532236269","brtmtt2@unife.it",{"type":30,"investigatorFullName":14,"investigatorTitle":31,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Associate Professor","100478358",false,"NCT05508932","Atrial Fibrillation in Beta-Thalassemia","Inclusion Criteria:\n\n1. Transfusion-dependent Beta-thalassemia;\n2. Follow-Up at the Cardiology Unit of the University Hospital of Ferrara;\n3. Electrocardiogram performed;\n4. Echocardiogram performed.\n\nExclusion Criteria:\n\n1. Age \\\u003C18 years;\n2. State Of pregnancy;\n3. Inability to give informed consent.","ALL","18 Years",{"count":40,"type":41},350,"ESTIMATED","OBSERVATIONAL","The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.",[45,46],"Atrial Fibrillation","Thalassemia",[45,46,48,49,50],"Thalassaemia","Arrhythmia","Hemoglobinopathies","2026-02-21",{"date":53,"type":54},"2026-02-24","ACTUAL",{"date":56,"type":54},"2022-09-01",{"date":58,"type":41},"2032-07-01",{"name":5,"class":6},1]